Genocea Biosciences (GNCA) Jumps: Stock Moves 12% Higher

Shutterstock photo

Genocea Biosciences, Inc. GNCA was a big mover last session, as the company saw its shares rise almost 12% on the day. The move came on solid volume with far more shares changing hands than in a normal session. This continues the recent uptrend for the company, as the stock is now up 24% in the past one-month time frame.

The company has seen one negative estimate revision in the last 30 days and its Zacks Consensus Estimate also moved lower suggesting trouble down the road. So make sure to keep an eye on this stock going forward to see if yesterday's move higher can last.

Genocea Biosciences currently carries a Zacks Rank #3 (Hold).

Genocea Biosciences, Inc. Price

Genocea Biosciences, Inc. Price | Genocea Biosciences, Inc. Quote

A better-ranked stock in the same industry is Neos Therapeutics, Inc. NEOS , sporting a Zacks Rank #1 (Strong Buy). You can see the complete list of today's Zacks #1 Rank stocks here .

Is GNCA going up? Or down? Predict to see what others think: Up or Down

8 Stocks with Huge Profit Potential

Just released: Driverless Cars: Your Roadmap to Mega-Profits Today. In this latest Special Report, Zacks' Aggressive Growth Strategist Brian Bolan explores a full-blown technological breakthrough in the making - autonomous cars. He also spotlights 8 stocks with tremendous gain potential to feed off this phenomenon. Click to see the stocks right now >>

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report

Genocea Biosciences, Inc. (GNCA): Free Stock Analysis Report

Neos Therapeutics, Inc. (NEOS): Free Stock Analysis Report

To read this article on Zacks.com click here.

Zacks Investment Research

The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.

This article appears in: Investing , Investing Ideas , Stocks
Referenced Symbols: GNCA , NEOS

More from Zacks.com




Equity Research

Research Brokers before you trade

Want to trade FX?